Table 1B. IC50s (nM) (mean+/−S.D.), generated using GraphPad Prism 7 Software, for crenolanib and AC220 tested against Ba/F3-FLT3-ITD and Ba/F3-FLT3-ITD+SYK-TEL. Cell growth assays were carried out for approximately 3 days.

	crenolanib (IC50, nM)	quizartinib (IC50, nM)
Ba/F3-FLT3-ITD	6.2+/−2	0.3+/−0.3
Ba/F3-FLT3-ITD+SYK-TEL	520.6+/−121.1	627.5+/−32.2